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ABSTRACT 
 
Aim: 
To evaluate the patients with chronic kidney disease stage 5 (CKD 5) and their prospective 
renal transplant donors regarding: 
1. The renal replacement choices made by the patients with CKD 5. 
2. To assess the medical and non-medical factors that affect living related renal donor 
selection among prospective renal transplant recipient. 
 
Methods: 
 Over 24 months, consecutive patients with CKD 5 and their relatives were interviewed at 
their presentation to the nephrology services of Christian Medical College, Vellore, and the 
reasons for the choice of modality chosen were analyzed and the prospective recipient and their 
donors were again interviewed separately and the medical and non medical factors that affected 
the donor selection were determined. 
 
Results: 
 1257 consecutive CKD 5 patients were enrolled over 24 months. Conservative, dialytic 
treatment and renal transplantation were chosen by 513 (40.8%), 320 (25.5%) and 424 (33.7%) 
patients. Only socioeconomic status affected significantly the modality chosen and not the age, 
gender or donor availability. Patients or donor were likely to withdraw from transplant 
evaluation commonly due to absence of voluntary donor , presence of a male donor, coercion not 
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to donate and absence of sponsorship either fully or partly. The commonest cause of rejection of 
a donor was ABO incompatibility (45.8%), followed by diabetes mellitus (DM) or risk of DM 
(24%), renal disease (5.9%), hypertension (5.5) and persistent cross match positivity (5.1). 
 
Conclusion: 
 The non medical factors that negatively influences the donor availability or withdrawal 
should be identified and to improve the rates of organ donation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
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Introduction: 
The chronic kidney disease is a worldwide public health problem with an 
increasing incidence and prevalence and hence an increasing number of patient are 
treated with renal replacement therapy —dialysis or transplantation. The annual 
incidence of ESRD has doubled over the past decade to reach about 135 per million in 
Europe and similar rate in USA. It is expected to continue to rise at an annual rate of 
around 5–8%. In India, the annual incidence is 34–240 per million population38. 
Two factors are important. The first is the ageing of the population; the incidence 
of ESRD is higher in elderly people than in the general population. The second factor is 
the global epidemic of type 2 diabetes mellitus; the number of people with diabetes 
worldwide (currently about 154 million) is predicted to double within the next 20 years.  
And in India as per the diabetes atlas 2006 published by the diabetes federation , the 
number of diabetes in India currently around 40.9 million is expected to rise to 69.9 
million by 2025 unless urgent preventive measures are taken. And with it there is an 
expected parallel epidemic of diabetic nephropathy. 
India currently has approximately 820 nephrologists, 710 hemodialysis units with 
2,500 dialysis stations and 4,800+ patients on CAPD. There are approximately 172 
transplant centers, two-thirds of which are in south India and mostly privately run. Nearly 
3,500 transplants are done annually, the total number of cadaver donors being 
approximately 700 till now. Thus, taken together, nearly 18,000–20,000 patients (10% of 
new ESRD cases) in India get renal replacement therapy. The cost of single hemodialysis 
varies between Rs. 750 and Rs. 2000 with an additional cost of erythropoietin being 
Rs.6000 - 8000/month. The cost of CAPD using a ‘Y’ set with 3 exchanges/week is Rs. 
16000/month. The cost of the transplant procedure in a state-run hospital is Rs. 40,000–
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50,000, and the cost of immunosuppression using tacrolimus, steroid and mycophenolate 
is Rs.15,000–18000/month39.  
The number of patients with ESRD probably underestimates the entire burden of 
CKD because the numbers with earlier stages of disease (stages 1 to 4) are likely to 
exceed by as much as 50 times those reaching ESRD (stage 5).  In the last two decades 
there has been an increasing evidence that the adverse outcomes of CKD like 
cardiovascular disease, premature death can be prevented or delayed. Earlier stages of 
CKD can be detected only through periodic health check ups and laboratory testing. 
Treatment at earlier stages of CKD is effective in retarding the progression towards stage 
5. Unfortunately, CKD is underdiagnosed and undertreated resulting in lost opportunities 
of prevention. 
In 2004 poor Indians spent 40 percent of their income on health care; the rich 
spent about 2.4 %. Studies have shown that medical expenses were one of the three main 
factors pushing people into poverty37.   
Data from India on the factors that determine the donor selection is lacking. This 
study was an effort to explore the medical factors and non medical factors that affect 
donor selection. The non medical factors are amenable to change as against the medical 
factors. So this study would form a background to see the magnitude of the problem and 
insights into the non medical factors that affect donor selection. 
 
 
 
 
 
 
 
 
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LTERATURE 
 
 
 
 
 
 
 
 
 
5 
 
Introduction: 
 
Chronic Kidney Disease (CKD) is a worldwide problem health problem. 
According to the World Health Organization Global Burden of Disease project, diseases 
of kidney and urinary tract contribute to 850,000 per year and 15,010,107 disability 
adjusted life years. This is grossly an underestimate and an unknown number of patient 
dying with heart disease may in fact have CKD as it is a known risk factor for 
progression of coronary artery disease. 
 
Indian Scenario: 
 
Incidence and Prevalence of CKD: 
 
Even in rural India chronic non communicable disease are emerging as the 
leading cause of mortality. There are only three community based CKD prevalence 
studies in the country1. The CKD prevention study based on urinary abnormalities and 
who responded to a questionnaire from rural areas around Chennai showed a prevalence 
of 0.86% in the study population and 1.36% in the control population2. In an urban study 
from Delhi the CKD prevalence based on a serum creatinine level of 1.8mg% or higher 
the prevalence was 0.79% or 7852 per million population3. The only longitudinal study 
that gave an estimate of the incidence of CKD, stage 5 was done in Bhopal; an urban 
centre gave an average crude incidence of 151 per million population4. 
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Availability of Renal Replacement Therapy: 
 
The widening gap between the need and availability of organ for transplantation is 
all too familiar. From 1988 to 1997, the number of people waiting for kidneys in the 
United States almost tripled, while the number of transplants increased by only 36% (a 
19% increase in cadaver transplants and a 102% increase in living-donor transplants). 
 
The magnitude of the problem is much greater in India, where about 80,000 
people reach end-stage renal disease (ESRD) annually and only 2000 receive transplants 
and the other 78,000 die5. As per an estimate in India 3,500 have renal transplantation 
done, 15,000 are started on maintenance hemodialysis and 3,000 are started on 
continuous ambulatory peritoneal dialysis in a year and nearly 21,500 patients, i.e., only 
10% of new ESRD cases get RRT6. 
  
The mean age of patients entering ESRD programs in the India is much lower (42 
years) as compared to the West (61 years) 7. Therefore, ESRD affects patients in the most 
productive years of their lives, and these patients are often the sole wage earners of their 
families. The lower mean age of patients with ESRD at least could be explained in part 
by the delay in diagnosis and failure to institute strategies delaying progression of chronic 
renal failure (CRF) to ESRD, and by the lower frequency of diabetic nephropathy due to 
type 2 diabetes mellitus. 
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Patients with CRF generally present late in the course of their disease, with 
66%patients first seeing a nephrologist when they are already in ESRD. Although in the 
developed and industrialized world, access to renal replacement therapy (RRT) is 
unrestricted and easily available, patients in India have to travel long distances to reach a 
kidney center because of misdistribution of renal services in India, with most of the 
centers being located in large cities. Furthermore, because of the virtual absence of health 
insurance plans, less than 10% of all patients with ESRD receive any kind of RRT. Most 
patients entering RRT programs in the country are funded by their employers or by 
charity organizations. In a study from a private sector hospital in south India, 63% 
patients belonged to this group, 30% arranged finances for their treatment by selling 
property, 20% raised loans and only 4% were able to take care of their treatment costs 
solely by pooling in family re-sources8.   
 
 
Renal Transplantation in India: 
 
Joseph Murray and his colleagues performed the first successful renal transplant 
in 1954. As immunosuppressive therapy developed, it became clear that transplantation 
could be performed on a large scale.  
 
There are approximately 45 major centers (0.05 pmp) performing transplants in 
India doing an estimated 3000 transplants per year. Living related donors constitute 30 to 
40% of all kidney donors in India. The type of kidney donors in a state funded, living-
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related kidney transplant program has provided interesting data on the exploitation of 
females as donors in the society. In this study, 37% of all donors were mothers and the 
kidney went mostly to the sons (76%); 29% donors were sisters and 88% of the 
beneficiaries of these kidneys were brothers. In all 66.4% of the donors belonged to the 
female sex  and 83.2% of all recipients were males, spouse donors (largely wives) 
account for more than 15% of all donors from within families9.  
 
Living donors and Morbidity and Mortality: 
 
The risk of death in donor nephrectomy is 1 in 320010. The centers come to terms 
with the possibility of harming living donors by being highly selective in their acceptance 
of the donors. The important issues regarding the donor, in addition to medical suitability, 
are whether the donor understands the risks of nephrectomy and whether the donor freely 
consents. 
  
Most follow-up studies of living kidney donors find no decrease in long-term 
survival. A follow-up of 430 Swedish donors between 1964 and 1994 found an 85% 
survival 15 months to 31 years after donation compared to a predicted 66% in the general 
population of similar age. The survival advantage was attributed to the selection bias11.  
 
Two concerns have emerged regarding the possibility that donors will develop 
end-stage renal disease. One is that hyperfiltration in the remaining kidney will lead to 
focal segmental glomerulosclerosis and renal failure, that is, donation per se will cause 
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renal failure. The second concern is that donors who develop primary renal disease will 
progress to renal failure more quickly because they have lower-than-normal renal mass at 
the onset of the primary renal disease. The latter concern applies particularly to patients 
with a family history that puts them at risk for renal disease, for example, family 
members of patients with type II diabetes. 
 
In a recent study by Hassan et al 12, at a mean follow up duration of 12.2±9.2 
years after donation, 85.5% of the subgroup of 255 donors had a GFR of 60 ml per 
minute per 1.73 m2 of body surface area or higher, 32.1% had hypertension, and 12.7% 
had albuminuria. Older age and higher body-mass index, but not a longer time since 
donation, were associated with both a GFR that was lower than 60 ml per minute per 1.73 
m2 and hypertension. A longer time since donation, however, was independently 
associated with albuminuria. Most donors had quality-of-life scores that were better than 
population norms, and the prevalence of coexisting conditions was similar to that among 
controls from the National Health and Nutrition Examination Survey (NHANES) who 
were matched for age, sex, race or ethnic group, and body-mass index. 
 
Many follow-up studies conclude that the majority of donors derive a tremendous 
degree of satisfaction and an increase in self-esteem from their donation. Most donors 
interviewed viewed their donation as an act of heroism and generosity with which 
nothing else in their lives compared. 
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Kidney donation is not without a financial burden, however. Although the 
medical expenses associated with renal donation are covered by the recipient’s insurance, 
23.2% of donors in one series of 536 reported financial hardship13. 
 
 
Who should be a living donor? 
 
Early in transplantation the donors were both related and unrelated. The reasons 
for abandoning the live unrelated donors are multiple. Initially before the cyclosporine 
era the results of unrelated donors were similar to the results of cadaveric transplantation. 
Data from the United Network for Organ Sharing (UNOS) registry published in 1995 
showed an 85% 3-year survival rate for kidneys from 368 spousal donors, 82% for 
kidneys from 3368 parental donors, and 70% for 43,341 cadaveric kidneys14. 
 
Friends as donors usually have been accepted with more reluctance than spouses. 
But the reluctance of physicians to accept or even encourage friends as donors does not 
take into account that friends would be less likely to feel pressured to donate than would 
a family member. 
 
Transplant centers regard the altruistic donor with suspicion. A 1968 survey of 54 
transplant centers reported that 50% disapproved of the use of living unrelated donors 
and only 20% had used them15. 
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The concern about psychopathology played a role in the reluctance to use 
altruistic donors. But the fear that was not substantiated in a study that had follow-up of 
18 unrelated donors, including 9 strangers, found no psychological complications or 
regrets after donation16. 
 
The paid donor, under the guise of altruism, has been a major factor in renal 
commerce in India, and laws have been passed there restricting donation to close 
relatives.  
 
The person who gives consent to be a donor should be competent, willing to 
donate, free of coercion, medically and psychosocially  suitable, fully informed of the 
risks and benefits as a donor, and fully informed of risks, benefits, and alternative 
treatment available to recipient. The benefits to both donor and recipient must outweigh 
the risks associated with the donation and transplantation of the living donor organ.  
Before donation, the live kidney donor must receive a  complete medical and 
psychosocial evaluation, undergo an appropriate informed consent process, and be 
capable of understanding the information presented in that process to make a voluntary 
decision.  
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Donor exchange:  
 
A significant number of patients are unable to undergo living donor transplant 
despite the availability of willing and otherwise suitable donors because of ABO 
incompatibility. Paired donation has been applied successfully in this setting, with 
excellent results in terms of patient and graft survival. Application of this on a large scale 
of paired donation programs surely will contribute to increase the chances of 
transplantation in this subgroup of candidates. However, at present, paired donation has 
not been able to help the vast majority of these patients18. 
 
Park et al from Korea had shown that the reasons for participating in the exchange 
process were ABO incompatibility (75.5%), poor HLA match (13.6%), and positive 
lymphocyte crossmatch (10.9%)19. 
 
ABO-incompatible renal transplant: 
 
The early dogma suggesting that ABO incompatibility should be considered an 
absolute contraindication to living donor kidney transplantation has been challenged 
successfully in the past 2 decades. However, this strategy exposes patients to an increased 
risk of early graft loss and a higher rate of acute rejection, as well as to the morbidity 
inherent to the necessary use of deconditioning protocols. 
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The first attempt at crossing the ABO barrier was made in 1955 by Hume et al.  
The initial attempts were complicated by hyperacute rejections. In 1964 Starzl et al 
reported 3 successful kidney transplants across the ABO barrier before better survival 
were reported later. With improvements in immunosuppression medications and intensive 
immunologic monitoring, results of A2 donors into O or B recipients have now reached 
outcomes equal to that of compatible donors20. Unfortunately, these interesting findings 
have been able to help only a minority of kidney transplant candidates with available 
ABO-incompatible living donors. 
 
When compared with a control group of 1,055 patients who underwent a 
compatible living donor transplant, graft survival rates were statistically better in the 
compatible donor group during the first 5 years, however, there was no difference beyond 
this point. Graft survival did not differ based on blood type incompatibility, human 
leukocyte antigen mismatch, or which calcineurin inhibitor was used21. 
 
Commercial renal transplantation: 
 
The arguments given for the ban on commercial transplantation are: 
 
(1) The donor’s choice is not voluntary because he is compelled by circumstances of 
poverty to donate a kidney. 
(2) Paid donors usually are poor and uneducated, so making them understand the risks is 
all but impossible. 
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(3) Commercial donation will result in the rich having access to organs for 
transplantation while the poor do not. 
(4) Donors will be exploited by unscrupulous middle-men and doctors. The medical care 
of both donor and recipient will suffer. 
(5) The poor don’t know how to handle the money that comes to them and it will make 
no permanent difference in their poverty. 
6) During its entire history, transplantation has relied on the altruism of donors and their 
families. Commercial donations would change the fundamental character of organ 
donation and likely would lead to the disappearance of altruistic donors. If any 
transplants are paid for, all will have to be. 
 
Although the sale of kidneys has been illegal in India since the passage of its 
Transplantation of Human Organs Act in 1994, donors have been able to convince an 
authorization committee of their kinship with the recipient after coaching from the broker 
and the recipient. 
 
In 1990, Thiagarajan and colleagues reported on their experience with 153 living 
related donors and 303 unrelated donors. At two-year follow-up, graft and patient 
survival were the same for related and unrelated donors. In the process of evaluation, 
72% of potential donors were rejected. Those who had come a long way in the evaluation 
process were paid a small sum for their trouble17. 
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The ongoing negative medical, socioeconomic and emotional impact of renal 
failure upon patients and their families and the financial incentives for donors appears to 
be driving the commercialization of organs for transplant. However, research suggests 
that medical, socioeconomic and emotional outcomes for both recipients and donors are 
poor. While recipients are exposed to the risks of surgery in poorly equipped unsanitary 
clinics thereby increasing the risk of infection, donors are, in the main, drawn from the 
lower socioeconomic groups from developing countries, who do not have access to 
follow up healthcare, or worse, they are carrying infectious diseases, such as TB, HIV or 
hepatitis22. 
 
Despite donors being motivated by the opportunity to improve their financial 
status, research has suggested that there is little or no economic improvement following 
donation. Indeed, in some cases (86% of those surveyed) the average family income 
actually declined by as much as one-third after donation23. 
 
Despite the act of donation having being viewed as a business transaction, there 
still appears to be a stigma attached to organ donation with one study suggesting that 
94% of the donors were unwilling to identify themselves as donors, even to close 
relatives24. 
 
Health Literacy and Access to Kidney Transplantation 
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The National Institutes of Health define health literacy as the ‘‘degree to which 
individuals have the capacity to obtain, process and understand basic health information 
and services needed to make appropriate health decisions.” Inadequate 
health literacy is common, found in one fourth to one third of previously studied 
populations, and has been linked to poorer health-related knowledge, more health care 
utilization, and worse outcomes25. 
 
Altruistic Living Donor 
 
The living donor transplant has increased a hundred fold in the last 10 years. Even 
though the possible increase in the number of the deceased donors can solve the problem 
of organ availability for donation the living donors will continue to be used due to a 
variety of reason including better cost effective renal replacement therapy. 
 
Recently, there has been mounting evidence of unexpectedly high rates of 
survival of kidney grafts from living unrelated donors, despite high degrees of HLA 
mismatch. These donors include individuals such as spouses, emotionally related 
individuals, and even altruistic donors. In a survey published in 1994, all adult renal 
transplant centers in the United States were asked for their views and practices regarding 
unrelated living kidney donation. Of those responding, the majority would accept either 
spouses or friends (>60% of responding centers) as donors, but only 15% would even 
consider using emotionally unrelated altruistic donors26. 
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The hesitancy to perform this procedure from these unconventional donors arises 
from a number of concerns. One of the arguments is the appropriate concern for the 
safety and welfare of the donor, particularly since the donor has a less favorable risk–
benefit profile. Since donor nephrectomy is a major surgical procedure, there is no doubt 
that living organ donation requires the intentional infliction of transient physical harm on 
these individuals. Barring any obvious medical contraindications to donation, there is no 
reason to think that the medical risk to an altruistic donor should be any greater than that 
of the more conventional living donor. Furthermore, the vast majority of donors have 
excellent long-term survival, at least as good as that of the general population27. 
 
The other major argument against the use of altruistic donors is based on ethical 
considerations. In some cases, there is concern about the donor's motivation, and that the 
establishment of using strangers as donors would set transplant medicine on a slippery 
slope toward commercialism of vital organs. However, there is no reason to believe that 
the desire to donate an organ to a stranger is necessarily a pathological obsession.  
 
Sadler et al., in a study of 18 unrelated living donors (nine of which were altruistic 
strangers), found no evidence of psychopathology, and post-hoc, none experienced 
psychological complications or regret following donation. Secondly, since the offer to 
donate is being made altruistically, there is a greater likelihood that the patient is truly 
acting autonomously without external pressure to undergoing the procedure; likewise, it 
may be argued that these individuals are the only living donors that can truly give an 
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informed consent, since there is are no overlying emotional concerns or sense of 
obligation that would invalidate voluntary consent28. 
 
A particularly important influence in the field of altruistic living donation is the 
work of the German Interdisciplinary Arbeitsgruppe Lebenspende, which was established 
to investigate in depth, the ethical, legal, psychological, and medical aspects of living 
organ donation. This group has concluded that, in principle, there are no ethical or 
medical grounds on which to exclude genetically unrelated living donors; rather, they 
have emphasized the need for a firm demarcation between acceptable and unacceptable 
types of living donation, based on reliable models and instruments that can objectively 
confirm altruistic motivation, genuine voluntariness and absence of coercion29. 
 
This has been incorporated into a prospective clinical trial that involves a series of 
lengthy interviews involving the potential donor and recipient and a mediating 
psychologist, leading to the signing of a transplantation contract. It is noteworthy that the 
German parliament has incorporated aspects of investigators' model into a bill making it 
unconstitutional to categorically exclude potential unrelated living donors if living 
donation is contemplated. 
 
Direct and indirect economic costs incurred by living kidney donors: 
 
Despite the many benefits of living donor kidney transplantation, economic 
consequences can result for donors. While expenditures for medical evaluation, surgery 
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and hospital care are generally covered through public or private insurance, donors are 
often responsible for other costs associated with the donation process30. 
  
The Human Organ Transplant Act 1994, India like many other organizations 
prohibits payment for organs and tissues for donation and transplantation but excludes 
from the reasonable reimbursement of expenses such as those incurred in procurement, 
transport, processing, preservation, and implantation from the definition of payment.  
 
The direct cost involved are for travel, accommodation, long distance phone calls, 
medical expense and the indirect costs involve lost income, hired caregiver cost, and 
others. Other individuals involved with the process of living kidney donation often 
experience costs as well. Persons who volunteer to donate, but do not proceed with 
donation, experience out-of-pocket expenses during the evaluation phase. Also, family 
members, spouses or friends who support donors by providing accompaniment to the 
transplant centre and care during convalescence may incur many of the costs that are 
relevant to donors31. 
 
Evaluation of a prospective donor: 37 
 
Acceptable donor renal function  
 
All potential kidney donors should have GFR estimated.  
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Creatinine-based methods may be used to estimate the GFR; however, creatinine 
clearance (as calculated from 24-h urine collections) may under or overestimate GFR in 
patients with normal or near normal renal function.  
Calculated GFR values (MDRD and Cockcroft-Gault) are not standardized in this 
population and may overestimate GFR.  
A GFR≤80 ml/min or 2 SD below normal (based on age, gender, and BSA corrected to 
1.73 per m2) generally preclude donation.  
 
Hypertension  
 
Patients with a BP>140/90 by ABPM are generally not acceptable as donors.  
BP should preferably be measured by ABPM, particularly among older donors (>50 
years) and/or those with high office BP reading.  
Some patients with easily controlled hypertension, who meet other defined criteria, e.g. 
<50 years of age, GFR >80 ml/min, and urinary albumin excretion <30 mg/day may 
represent a low-risk group for development of kidney disease after donation and may be 
acceptable as kidney donors.  
Donors with hypertension should be regularly followed by a physician. 
 
Obesity  
 
Patients with a BMI>35 kg/m2 should be discouraged from donating, especially when 
other comorbid conditions are present.  
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Obese patients should be encouraged to lose weight before kidney donation and should 
be advised not to donate if they have other associated comorbid conditions. 
Obese patients should be informed of both acute and long-term risks, especially when 
other comorbid conditions are present.  
Healthy lifestyle education should be available to all living donors.  
 
Dyslipidemia 
 
Dyslipidemia should be included along with other risk factors in donor risk assessment, 
but dyslipidemia alone does not exclude kidney donation.  
 
Urine analysis for protein  
 
A 24 h urine protein of >300 mg is a contraindication to donation.  
Microalbuminuria determination may be a more reliable marker of renal disease but its 
value as an international standard of evaluation for kidney donors has not been 
determined. 
 
Urine analysis for blood  
 
Patients with persistent microscopic hematuria should not be considered for kidney 
donation unless urine cytology and a complete urologic work up are performed. If 
22 
 
urological malignancy and stone disease are excluded, a kidney biopsy may be indicated 
to rule out glomerular pathology such as IgA nephropathy. 
 
Diabetes  
 
Individuals with a history of diabetes or fasting blood glucose ≥126 mg/dl (7.0 mmol/l) 
on at least two occasions (or 2 h glucose with OGTT≥200 mg/ dl (11.1 mmol/l) should 
not donate. 
 
Stone disease  
 
An asymptomatic potential donor with history of a single stone may be suitable for 
kidney donation if:  
No hypercalcuria, hyperuricemia, or metabolic acidosis.  
No cystinuria or hyperoxaluria.  
No urinary tract infection.  
If multiple stones or nephrocalcinosis are not evident on CT.  
An asymptomatic potential donor with a current single stone may be suitable if:  
The donor meets the criteria shown previously for single stone formers and current stone 
<1.5 cm in size, or potentially removable during the transplant. 
 
Stone formers who should not donate are those with:  
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(a) Nephrocalcinosis on X ray or bilateral stone disease and  
(b) Stone types with high recurrence rates, and are difficult to prevent    
 
Malignancy  
 
A prior history of the following malignancies usually excludes live kidney donation:  
Melanoma, testicular cancer, renal cell carcinoma, choriocarcinoma, hematological 
malignancy, bronchial cancer, breast cancer, and monoclonal gammopathy. 
 
A prior history of malignancy may only be acceptable for donation if:  
Prior treatment of the malignancy does not decrease renal reserve or place the donor at 
increased risk for ESRD.  
Prior treatment of malignancy does not increase the operative risk of nephrectomy.  
 
A prior history of malignancy usually excludes live kidney donation but may be 
acceptable if.  
The specific cancer is curable and potential transmission of cancer can reasonably be 
excluded.  
 
Urinary tract infections  
 
The donor urine should be sterile before donation; asymptomatic bacteruria should be 
treated pre donation.  
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Pyuria and hematuria at the proposed time of donation is a contraindication to donation.  
Unexplained hematuria or pyuria necessitates evaluation for adenovirus, tuberculosis, and 
cancer. Urinary tuberculosis or cancer are contraindications to donation. 
 
Acceptable donor renal function 
Live unrelated donors 
The current available data suggest no restriction of live kidney donation based upon the 
absence of an HLA match. An unrelated donor transplant is equally successful to the 
outcome achieved by a genetically related family member such as a parent, child, or 
sibling, who is not HLA identical to the recipient. 
 
Determination of cardiovascular risk 
 
The clinical predictors of an increased perioperative cardiovascular risk (for non-cardiac 
surgery) by the American College of Cardiology /American Hospital Association 
standards fall into three categories: major, intermediate, and minor. 
All major predictors: unstable coronary syndromes, decompensated heart failure, 
significant arrhythmias and severe valvular disease are 
contraindications to live kidney donation. Most of the intermediate predictors: mild 
angina, previous myocardial infarction, compensated or prior heart failure, and diabetes 
mellitus are also contraindications to donation. Minor predictors: older age, abnormal 
ECG, rhythm other than sinus, low cardiac functional capacity, history of stroke, or 
uncontrolled hypertension warrant individual consideration. 
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Assessment of pulmonary issues 
 
A careful history and physical examination are the most important parts of assessing risk. 
Routine preoperative PFT is not warranted for potential live kidney donors unless there is 
an associated risk factor such as chronic lung disease. Increased risk of post operative 
pulmonary complication is assoc with an FEV1<70% or FVC<70% of predicted, or a 
ratio of FEV1/FVC<65%. 
 
Smoking cessation and alcohol abstinence 
 
Smoking cessation at least 4 weeks before donation is advised based on recommendations 
for patients undergoing elective surgical procedures. 
Cessation of alcohol abuse defined by DSM-3: 60gm of alcohol/day sustained over ≥6 
months should be avoided for a minimum of 4 weeks to decrease the known risk of 
postoperative morbidity. 
 
Components of the psychosocial evaluation of living kidney donors: 
Sociodemographic history and current status 
• Educational attainment, living situation, religious beliefs and practices, marital 
status, and employment. 
Capacity  
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• Cognitive status and capacity to comprehend information; risk for exploitation by 
others for monetary or other personal gain. 
Psychological status  
• Presence of current and past psychiatric disorder, including mood, anxiety, 
substance use, personality or other serious disorders.  
• Current and past use of therapeutic interventions (counseling and medications) for 
psychological or other stressors including sexual abuse, or for chronic pain 
management. Nature of coping skills to manage current or past life or health-
related stressors. 
Relationship with transplant candidate 
• Nature and degree of relationship (if any) to transplant candidate; whether 
donation would impose expectations or perceived obligations. 
Motivation  
• Rationale and reasons for volunteering to donate; perceived coercion or undue 
pressure by others to donate. 
Knowledge, understanding, and preparing for donation 
• Awareness of short- and long-term risks for surgical complications and health 
outcomes; understanding of recovery and recuperation time; availability of 
alternative treatments for the transplant candidate. 
Social supports  
• Spouse or other significant family members’ support for proceeding with 
donation; support from other sources (friends and employer). 
Financial status and suitability  
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• Financial stability and freedom from current or expected financial hardship; 
availability of resources to cover expected and unexpected donation-related 
expenses; availability of disability and health insurance. 
 
Marginal Donors: 
 
Expanded criteria deceased organ donors (ECD) are a source of kidneys that permit more 
patients to benefit from transplantation. ECD is defined as all deceased donors older than 
60 years and donors older than 50 years with 2 of the following: hypertension, stroke as 
the cause of death, or preretrieval serum creatinine greater than 1.5 mg/dl. The waiting 
list has become a “waiting to die” list, as 5% of patients on the kidney waiting list die 
each year.  
 
The decision to use an ECD kidney is complex because there are data to suggest that 
these kidneys have a higher rate of primary non function, DGF, rejection, and a greater 
susceptibility to preservation injury, drug toxicity, and the effects of post transplant 
hypertension.  In addition, ECD kidneys are believed to be more resource-intensive and 
costly.  Moreover, the longevity of an ECD kidney is believed to be much shorter, with 
the half-life estimated to be 4 to 6 years compared with 8 to 12 years with a standard 
criteria donor kidney. However allocation of the ECD kidney to ‘marginal recipients’ 
improves outcome and reducing waiting time.38 
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Post donation issues 
 
1. Short-term issues like activity restriction, incisional pain 
2. Long-term care like annual evaluation and emphasis on healthy lifestyle, review 
of medications and avoidance of nephrotoxic medications. 
3.  Effects of unilateral nephrectomy 
a) Deaths before discharge - 0.03% (UNOS data between 1999 and 2002)  
b) Short term effects like pain, bleeding, infections 
c)  Long term like proteinuria, development of ESRD, hypertension, 
pregnancy and pregnancy outcomes32 
 
Factors influencing Donor Availability 
 
This is a neglected area where in the due to social and perception of the 
complications of donation by the donor, family members or even the recipient can affect 
the act of voluntary donation. In India, the Human Organ Transplantation Act of 1994 
and its amendments discourages unrelated transplant due to ethical reasons and to avoid 
exploitation of the financially disadvantaged people. And with the increasing incidence 
and prevalence of diabetes and other non communicable diseases the availability of 
donors is restricted from an already limited donor pool.  
 
As per the Human Organ Transplantation Act of 1994 and its amendments 
discourages biologically unrelated transplant due to ethical reasons and to avoid 
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exploitation of the financially disadvantaged people.  This in addition to medical and 
other non medical factors affects the donor availability adversely.  
 
Psychosocial reasons for donor non availability 
 
In 1987 in the USA 25% of all renal transplantations were performed with living 
related donors, while in Europe only 11% of all transplanted kidney patients received a 
kidney from a living donor. In a study involving 139 patients in the Netherlands Sixty-six 
percent of all potential offers did not result in transplantation, approximately 35% due to 
immunological reasons, including ABO incompatibility and almost 30% due to medical 
reasons in the potential donor. In the majority of cases the medical reasons were due to 
some form of renal abnormality; 10% of all potential donors were excluded for this 
reason. The high incidence of renal disease of the potential donors could be due to 
genetic influences. 
 
In another study that retrospectively addressed the effects of the organ donation 
process in 536 donors living related kidney donors the majority (69.5%) of the subjects 
volunteered to come without having been solicited.  The parents were the recipients in the 
majority (93.1%) of the unsolicited volunteers.  A substantial majority of the donors 
indicated that neither their families (85.8%), nor their friend (86.2%), nor the health care 
professionals with whom they had contact (93.7%) had attempted to influence their 
decision. Individuals were more likely to receive pressure from their family to donate if 
the recipient was a parent and while family pressure not to donate was substantially more 
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prevalent if the recipient was a sibling. The subjects who experienced pressure to donate 
from their friends notably more frequently reported donation to have been a financial 
burden.  
 
It was apparent in the above study that in excess of 14.0% of the donors had 
experienced direct pressure, particularly not to donate, from their families or friends. This 
finding suggests the need to recognize the influence of the potential donor’s social 
network, to provide those individuals with appropriate information on kidney donation, 
and possibly to include them in the decision-making process. 
 
Sequel of donor nephrectomy: 
 
In a recent involving 255 donors followed up for a mean duration of 12.2±9.2 
years the glomerular filtration rate (GFR) and urinary albumin excretion were assessed 
and it was found that the prevalence of hypertension, general health status, and quality of 
life is similar to that of persons who have not donated a kidney. The risk of ESRD does 
not appear to be increased among donors, and their current health seems to be similar to 
that of the general population. In addition, their quality of life appears to be excellent. 
The rate of change in the GFR did not appear to accelerate over time. The prevalence of 
hypertension and albuminuria in kidney donors were similar to those in controls who 
were matched for age, sex, race or ethnic group, and body-mass index, even two decades 
after donation12. 
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AIMS AND OBJECTIVES 
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Aim: 
To evaluate the patients with chronic kidney disease stage 5 (CKD 5) and their 
prospective renal transplant donors regarding: 
1. The renal replacement choices made by the patients with CKD 5. 
2. To assess the medical and non-medical factors that affect living related renal 
donor selection among prospective renal transplant recipient. 
 
Objectives: 
All the patients with CKD 5 attending the nephrology out patient department from 
December 2006 to November 2008 were prospectively screened and the patients with 
CKD 5 were interviewed in detail. And the prospective recipient and their respective 
donors are interviewed again on separate occasions. The factors studied are: 
1. Demographic features of the patients and their prospective donors 
2. Socio-economic status using modified Kuppuswamy’s (urban) socioeconomic 
score  
3. Reason for choosing a specific modality of renal replacement therapy. 
4. Total possible number of first degree related donors. 
5. Medical and non medical factors that is likely to affect the donor selection. 
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6. The reasons for withdrawal from the renal transplant program.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODOLOGY 
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Study Design: 
The study was a cohort study on consecutive patients with chronic kidney disease 
stage 5 (CKD 5) who presented to the nephrology services of Christian Medical College, 
Vellore. The renal replacement options chosen by the patients and the medical and non 
medical factors that determine the living kidney donor selection were studied.   
Setting: 
The study was conducted among the out-patients of the department of nephrology, 
units 1 and 2 of the Chritian Medical College (CMC), Vellore, South India which is a 
2300 bedded tertiary care teaching hospital. Nephrology serves are being offered for the 
last 35 years. 
Subjects 
Inclusion Criteria: 
a) Subjects newly diagnosed as cases of CKD 5 based on history, calculated 
abbreviated MDRD (Modification of Diet in Renal Disease) estimated GFR 
(Glomerular Filtration Rate) equation. 
b) They had compatible ultrasonographic evidence of CKD 5. 
Exclusion Criteria: 
a) The study excluded subjects who had been diagnosed to have CKD at CMC prior 
to the study period. 
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b) The study excluded cases of renal insufficiency where the diagnosis of chronicity 
was in doubt and required verification by further investigations. 
 
Evaluation: 
 
Consecutive patients with CKD 5 presenting to nephrology services from 
December 2006 to November 2008 were prospectively enrolled upon making a diagnosis 
of CKD 5. The patients and the relatives were interviewed by the investigator with regard 
to the renal replacement options planned and the prospective recipients and their 
prospective donors were interviewed separately and the medical and non medical factors 
that could possibly have a bearing on the selection and rejection or withdrawal of a 
particular donor was analyzed.  The data thus collected was then entered into an 
electronically compatible proforma. 
 
Statistical Analysis: 
 
Summary statistics and tests of significance (Chi square tests for categorical 
variables and student t tests for continuous variables) were calculated using SPSS version 
14 software package. 
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RESULTS: 
 
Choice or Renal Replacement therapy Chosen: 
 
Figure - 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fit for TX        : 485 
          No Donor    : 16 
          No Money    : 466 
          Have Both    : 3 
 
Not fit for TX    : 28 
 
Fit for TX  : 232 
           No Donor    : 15    
           No Money   : 217 
 
Not fit for TX :   69 
Came for Transplant 
Evaluation:  (382) 
  Transplant 
(424) 
 Dialytic Therapy        
(320) 
 CKD, Stage 5 (1257) 
 Conservative Treatment (513) 
Left     : 207 
No Donor   : 73 
Transplant Done   : 154 
Awaiting Transplant  : 21  
Recipient Left – 207 
• ABO incompatibility – 143 
• Diabetes Mellitus or Risk – 51 
• Hypertension – 15 
• Renal Disease - 13 
• Persistent Cross Match positive – 17 
• Liver disease or Hepatitis Viral Carrier - 5 
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Out of the 1257 CKD 5 patients 513 (40.8%) had chosen conservative treatment 
and poor finances influenced the decision in 466 (96.1%) of the 485 patients who 
otherwise was fit for being a renal transplant recipient. Only 16 patients did not have a 
single donor as per the age criteria of > 20 years and < 60 years.  
 
A similar trend was seen among the 320 (25.5%) patients who chose dialytic form 
of renal replacement therapy. Here 217 (93.5%) of the 232 patient fit to be a renal 
transplant recipient’s decision was influenced by poor finances. 
 
Of the 1257 patients with CKD stage 5, 424 (33.7%) chose renal transplant as 
their modality of treatment and of these only 382 (90.1%) came for recipient evaluation.  
Study of the prospective transplant recipients showed 73 (19.1%) of the 382 patients did 
not have a single donor and that contributed to 35.3% (73/207) of the prospective 
recipients who left our transplant program. 
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Figure – 2, Age and Choice of Renal Replacement Therapy 
 
N = 1257 
 
 
 
 
 
 
 
 
 
 
 
 
Though there was a trend towards older patient choosing maintenance dialysis as a 
modality of renal replacement therapy and younger people choosing renal replacement 
therapy it was not statistically significant. In addition, the number of patients choosing 
conservative treatment was not different across the various age groups suggesting age 
was not a major factor influencing the choice of therapy. 
 
Figure –3, Gender and Choice of Therapy 
 
N = 1257 
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Similarly gender had no influence on the choice of therapy and the difference 
across the groups was not significantly different. 
Figure – 4, Monthly Income and Choice of Therapy 
 
N = 1257 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was a significant difference in the monthly family income of the there 
treatment groups with higher income group preferentially opting for transplant and 
dialysis compared to the lower income groups. 
 
 
Figure – 5, Education and Choice of Therapy 
 
N =1257 
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Higher proportion of patient with better education chose renal transplant over the 
other modalities as shown in the above figure and the difference was statistically 
significant. 
Demography of the Prospective Transplant Recipients 
 
Table – 1, Age – Prospective Renal Transplant Recipients 
 
Age Group 
N = 382 
No. of Patients Percentage 
 
< 10 03 0.8 
10-19 21 5.5 
20-29 86 22.5 
30-39 85 22.3 
40-49 87 22.8 
50-59 86 22.5 
60-69 14 3.7 
 
 The mean age of the recipient who came for evaluation was 38.47 ± 13.02 years 
and the range was from 6 years to 65 years.  
 
 
Figure – 6, Gender and Marital Status– Prospective Renal Transplant Recipients 
 
N =382 
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The recipient population under study was predominantly male forming 74.6% of the 
cases (285 of 382 cases). As illustrated two-third of the recipients were married. 
Socio-economic status: 
Table – 2, Education – Prospective Renal Transplant Recipients 
 
Level of Education 
N = 382 
No. of Patients Percentage 
 
Illiterate 01 0.3 
Primary School or Literate 06 1.6 
Middle School Certificate 14 3.7 
High School Certificate 56 14.7 
Intermediate or Post High 
School Certificate 
106 27.7 
Graduate or Post Graduate 183 47.9 
Professional or Honors 16 4.2 
 
The majority of the prospective transplant recipients, i.e., 94.4% had a level of 
education better than high school certificate and only one patient was illiterate. 
 
 
 
 
Table – 3, Occupation – Prospective Renal Transplant Recipients 
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Occupation 
N = 382 
No. of Patients Percentage 
 
Unskilled Worker 34 8.9 
Semi-skilled Worker 35 9.2 
Skilled Worker 103 27.0 
Clerical, Shop owner, Farmer 116 30.4 
Semi-Professional 62 16.2 
Professional 32 8.4 
 
 
As per the modified (2003) Kuppusamy classification (urban) only 18.1% of the 
prospective transplant recipients were semi-skilled or unskilled workers, 24.6% were 
semi-professional or professional and the rest were skilled workers or were self employed 
or were doing clerical jobs. 
 
 
 
Table – 4, Socioeconomic Status– Prospective Renal Transplant Recipients  
 
Socioeconomic Class 
N = 382 
No. of Patients Percentage 
 
Upper 29 7.6 
Upper Middle 253 66.2 
Middle 94 24.6 
Upper Lower  6 1.6 
Lower 0 0 
 
 
None of the patient belonged to low socioeconomic status and 90.8% were either 
upper middle class or middle class. 
 
 
 
 
 
Table – 5, Blood Groups – Prospective Renal Transplant Recipients & Donors 
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ABO Blood Group 
N =382 
No. of Patients 
Recipient (Percentage) 
No. of Patients 
Donor (Percentage) 
O POS 193  (50.5) 132   (34.6) 
A POS 69    (18.1) 25     (6.5) 
B POS 95    (24.9) 56     (14.7) 
AB POS 19    (5.0) 3       (0.8) 
O  NEG 4      (1.0) 3       (0.8) 
A NEG 1      (0.3) 0       (0) 
B NEG 1      (0.3) 2       (0.5) 
Pos -  Positive, Neg - Negative 
 
 
The commonest blood group in both the recipient and the donor population were 
O positive and B positive. The O positive blood group was seen in 50.5% of the 
recipients while it was seen in only 34.6% of the prospective donors.  
 
 
Table – 6, Recipient Donor Relationship, N= 382 
 
 
Donor Relationship to 
Recipient 
No. of Patients Percentage 
 
Mother 81 21.2 
Brother 75 19.6 
Sister 63 16.5 
Wife 47 12.3 
Father 41 10.4 
Cousin Brother 20 5.2 
Son 14 3.7 
Husband 11 2.9 
Step Brother 8 2.1 
Cousin Sister 6 1.6 
Uncle 4 1.0 
Unrelated 4 1.0 
Step Mother 2 0.5 
Nephew 2 0.5 
Brother In Law 2 0.5 
Aunt 1 0.3 
Daughter 1 0.3 
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As our program strongly encourages first degree relatives to donate most of 
donors were near relatives. Mother was the donor in 21.2% of cases and brother, sister, 
father were donors in 19.6%, 16.5% and 10.4% respectively. Spouse came forward for 
donation in 68 (15.2%) out of 382 cases. 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure – 7, Donor Tree 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Total Family 
Members 2224 
Potential Donors 
1725 
Felt ABO 
Incompatible, 152 
Rejected For Donation 
613 
Donors Not Asked 
600 
Declined To Donate 
123 
Male: 884 
Female: 853 
Donors available  
(Including those not 
asked)  837 
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Table – 7, Requested To Consider Donation  
 
N = 382 No. of Patients Percentage 
 
Recipient 113 29.6 
Donor Came Forward 107 28.0 
Recipient’s Physician 98 25.7 
Recipient’s Spouse 27 7.1 
Recipient’s Family Member 37 9.7 
 
  
 The donor was first asked by the recipient in 29.6% of cases and the 
donor being a first degree relative in most instance came forward himself/herself in 28% 
of the cases. The recipient physician also had suggested the donor in 25.7% of the cases. 
 
 
 
Donors available 
(Excluding those not 
asked) 264 
Near relative other than first degree 
relative and spousal donor 
45 
No donor available for 73 
recipients 
Donors available for 
309 recipients 
Recipient Left – 207 
• ABO incompatibility – 145 
• Diabetes Mellitus or Risk – 51 
• Hypertension – 15 
• Renal Disease - 13 
• Persistent Cross Match positive – 17 
• Liver disease or Hepatitis Viral Carrier - 5 
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Table – 8, Attempted To Influence Donation 
 
N = 382  No. of Patients Percentage 
 
None 336 88.0 
Donor’s Spouse 22 5.8 
Uncle 11 2.9 
Mother-in-law 9 2.4 
Recipient’s Physician 4 1.0 
 
  
 In 46 (22%) of cases there was at least one instance of an attempt to 
discourage donation and the donor’s spouse was the commonest identified cause in 
47.8% of the cases. 
 
 
 
Table – 9, Reason for Declining to Donate 
 
N = 71 No. of Patients Percentage 
 
Spouse Declined To Consent 36 50.7 
No Specific Reason Disclosed 32 45.1 
Spouse (Donor) Wanted to 
Take care of the Recipient 
2 2.8 
Horse Shoe Kidney 1 1.4 
 
  
 The commonest reason for a donor not coming forward to donate was 
due to spouse’s negative coercion followed by no disclosed reasons for not donating. One 
case of donor withdrawing consent was due to horseshoe kidney in the donor. 
 
 
Figure -8, Expenditure for Transplant, N = 382 
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 Out of the 382 prospective recipients 56.8% (217/382) were not 
supported either fully or partly by governmental or non governmental institutions or by 
insurance.  
Table – 10, Reason for Rejection of a Donor  
 
 
N = 613 No. of Patients Percentage 
 
ABO incompatibility 281 45.8 
Diabetes Mellitus* 147 24.0 
Renal Disease 36 5.9 
Proteinuria 17  
Renal Calculi 12  
eGFR# <60 ml/min 5  
Cortical Scar 2  
Hypertension** 34 5.5 
Persistent Cross Match Positive 31 5.1 
Liver Disease*** 22 3.6 
Ischemic Heart Disease 17 2.7 
Unrelated Donor 10 1.6 
Pregnancy 4 0.7 
Sickle Cell Anemia/Trait 4 0.7 
Family h/o ADPKD 4 0.7 
Rheumatoid Arthritis 2 0.3 
49 
 
Thyroid Malignancy 2 0.3 
Seizure Disorder 2 0.3 
SLE 1 0.2 
Autoimmune Hemolytic Anemia 1 0.2 
Bronchial Asthma (Severe Persistent) 1 0.2 
Mental retardation 1 0.2 
Depression 1 0.2 
Suspected Renal Cell Carcinoma 1 0.2 
RHD Severe Mitral Stenosis 1 0.2 
 
* DM - Diabetes Mellitus or Family history of Diabetes Mellitus in a first-degree relative 
# Abbrv. MDRD eGFR <60 ml/min 
** Hypertension – Hypertension before 40 years or requiring more than 2 drugs at control 
of blood pressure 
*** Liver Disease – Cirrhosis, HbsAg +, HCV antibody +, Non Alcoholic Fatty Liver, 
Alcoholic liver disease 
 
 The commonest cause was ABO incompatibility 45.8 %(218/613) 
followed by diabetes mellitus or risk of diabetes mellitus 24% (147/613) and renal 
disease 5.9% (36/613) in a prospective donor. 
 
Table –11, Cause for Delay in Transplant Surgery 
 
 
 
N =  382 No. of Patients Percentage 
 
No Delay* 34 8.9 
Left Before HLA/Cross Match  95 24.9 
Investigational Delay** 101 26.4 
Money 39 10.2 
Persistent Cross Match Positivity 31 8.1 
CAG  16 4.2 
PTCA 8 2.1 
HLA could not establish relationship 9 2.3 
Catheter Sepsis 8 2.1 
HCV treatment 8 2.1 
Uremic Cardiomyopathy 7 1.8 
On ATT for TB 5 1.3 
Nephrectomy 4 1.0 
UTI 4 1.0 
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Evaluation for Debilitating Neuropathy 3 0.8 
Valve Replacement 2 0.5 
MRSA in Throat 2 0.5 
Hypothyroidism Treatment  2 0.5 
Epidural Hematoma 1 0.3 
Communication Problem 1 0.3 
Acute Hepatitis 1 0.3 
Suspected Fungal Sinusitis 1 0.3 
 
* No Delay – Transplant surgery within 30 days after starting evaluation for transplant 
** Investigational Delay – Delay due to government procedures and not due to money or 
medical issues. 
 
 There was delay in getting a renal transplant surgery done in 91.1% of 
patients. The medical reasons contributed to 29.6% of the delay. And the commonest non 
medical reason was due to government procedures 26.4% (101/382). 
 
 
 
Table: 12, Characteristics of patient who Left vs. who got Transplantation 
done/Waiting 
 
 N = 382 Transplant done 
/ Awaiting 
 Left p-value 
 
Socioeconomic Status   
Upper 12 18 
Upper middle 109 142 
Middle 48 46 
Upper middle 5 1 
ns 
Marital status   
Married 122 132 
Unmarried 52 74 
Widow/widower 1 1 
ns 
Decline to donate   
Nil 149 164 
≥ 1 26 43 
ns 
Rejected   
Nil 74 79 
≥ 1 101 128 
ns 
No donor 21 62 0.00 
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Donor gender    
Male 71 115 
Female 104 92 
0.03 
Donor Marital status   
Unmarried 35 59 
Married 129 138 
Divorcee 4 8 
Widow/Widower 7 2 
ns 
Relationship to donor   
Mother 48 34 
Brother 33 42 
Sister 28 35 
Wife 24 22 
Father 16 25 
Others 82 49 
ns 
Requested to consider donation   
Recipient 56 57 
Came forward himself/herself 54 54 
Recipient’s physician 45 52 
Recipient’s spouse 8 19 
Recipient’s family other member 12 25 
ns 
Attempted to influence decision 17 29 0.013 
Perception of complication (Unsure or likely) 69 86 ns 
Source of Finance    
Self 84 132 
Sponsored 91 75 
0.05 
  
 
 
Characteristics of patient who Left vs. who got Transplantation done/Waiting 
 
 
 
 The risk factors we identified among the prospective recipients who left 
our program were – absence of donor, presence of male donor, attempted coercion 
to donate and absence of financial support by the governmental or non 
governmental institutions either fully or partly.  
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DISCUSSION 
 
 
 
 
 
 
 
 
Discussion: 
 
Chronic kidney disease incidence and prevalence in India and worldwide is 
increasing and has become an important public health problem. Though life style 
modification, prevention and early detection of the of chronic kidney disease prolong life 
with reasonable quality. 
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The ever-widening gap between the numbers of people waiting for renal 
transplantation is all too familiar. In our country, our perception of the patient’s choice of 
the modality of renal replacement therapy is that it is largely dependent on the means of 
financial support for transplantation followed by donor factors. We evaluated if that was 
really the case. 
 
The mean age of the CKD 5 was 43.8±13.3 years and the mean age of the patient 
who had chosen renal transplant as their modality was 38.5±13.02 years. However, we 
observed that age did not have a significant influence on the modality chosen.  
 
The males constituted 77.2% of the total population of chronic kidney disease, 
stage 5 population. This was comparable to the 69.6% as per the Indian CKD registry33. 
Though it is tempting to believe that it may be due to socio-economic factors that more 
males had sought medical attention it is likely that the incidence of the disease per say is 
more in males. In a study by P. Jungers et al in a French urban area, the male female ratio 
was 2:1 after the age of 20 years onwards34. In a hospital based data from south India 
showed a prevalence of 60-70% of males with CKD2. However in an urban community 
based study from India only 48% of the population with any stage of CKD was males3. 
 
There was no significant difference in the male-female ratio (70:30) in the three 
modality of therapy chosen by the patient suggesting that age and gender were not the 
major factors involved in choosing a particular modality of renal replacement therapy. 
Even in countries where the treatment is state sponsored males outnumber females. Some 
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of the gender difference in prevalence may be due to risk factors shared by cardiovascular 
disease and end stage renal failure, both of which are commoner in men. 
 
There was a significant difference in the monthly family income, education status 
and socioeconomic status of the three treatment groups with higher income group and 
patients with better education opting for transplant and dialysis compared to the group 
that chose conservative treatment. Hence, patients with better socio-economical status 
more often chose dialytic form of therapy or renal transplantation. In our study, only 
7.6% (96/1257) are fully sponsored and 5.5% (69/1257) were partly sponsored by 
governmental or non-governmental organizations for the treatment expenses.  In 2004 
poor Indians spent 40 percent of their income on health care; the rich spent about 2.4 %. 
Studies have shown that medical expenses were one of the three main factors pushing 
people into poverty38.  Hence it is not surprising that a large proportion of patients chose 
conservative treatment. 
 
 
We did not evaluated the ‘health related literacy’ as a part of our study with 
instruments like Short Test of Functional Health Literacy in Adults (STOHFLA) which 
would have affected the decision making process. However the majority of the 
prospective transplant recipients, i.e., 94.4% had a level of education better than high 
school certificate and only one patient was illiterate.   
As per the modified Kuppusamy classification (urban) 35 only 18.1% of the 
prospective transplant recipients were semi-skilled or unskilled workers, 24.6% were 
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semi-professional or professional and the rest were skilled workers or were self employed 
or were doing clerical jobs. None of the patient belonged to low socioeconomic status 
and 90.8% were either upper middle class or middle class.  
 
The number of patients who chose conservative treatment, dialytic treatment and 
renal transplant were 40.8%, 25.5% and 33.7% respectively as against the Indian CKD 
registry data 75.1%, 22.5% and 2.5% respectively33.  Of the 33.7% of the patients who 
had chosen renal transplant as their modality of treatment 54.2% (207/382) had left for 
various reasons leaving only 13.9% of the initial population of 1257 with us for further 
evaluation.  Such a large number of patients choosing renal transplantation as a modality 
can be due to two reason. The first is due to the fact that only 17.7% (68/382) patients 
were from the neighboring districts of Tamil Nadu, Andhra Pradesh and Kerala and a 
large number came with plans for renal transplant. The second is due to centre effect and 
patients come here particularly for transplant surgery. 
 
As our program strongly encourages first-degree relatives to donate, most of 
donors were near relatives. Mother was the donor in 21.2% of cases and brother, sister, 
father were donors in 19.6%, 16.5% and 10.4% respectively. Spouse came forward for 
donation in 68 (15.2%) out of 382 cases. For the 172 patients who either had a transplant 
or were in the final stages of evaluation 70.9% were males and the females were the 
donor for 59.8% (103/172) of the recipients. Muthusethupathi et al from a state funded 
hospital from the state of Tamil Nadu, India had reported that two-third of their donor 
population was females and this had only marginally changed over the last 10 years36.  
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And hence despite the increasing rates of transplant surgeries there is still exploitation of 
the female gender as a donor in our country. Unlike our country the donation rates in the 
western countries is close to unity. Interestingly for the 1725 possible age matched 
donors for all the 382 prospective recipients in our study the male- female ratio was 1:1 
(884 male, 853 females). 
 
The cultural factors are a possibility but we wanted to see if there are other factors 
that influence the choice of a female donor. The donor was first asked by the recipient to 
donate in 29.6% of cases and the donor being a first degree relative in most instance 
came forward himself/herself in 28% of the cases. The recipient physician also had 
suggested the donor in 25.7% of the cases. The female donors who donated either 
voluntarily came forward or were requested by their recipients to donate. Other family 
members or the recipient’s physician did not influence their decision.  
 
Among the donors who had come for evaluation in 46 (22%) cases there was at 
least one instance of an attempt to discourage donation and the donor’s spouse was the 
commonest identified cause in 47.8% of the cases. The other family members constituted 
the rest.  
 
The reported cause for some of the possible donors declining to come forward for 
donor evaluation was again the spouse refusing to give consent. And in the rest no reason 
was disclosed. This emphasis the fact that the donor’s spouse must be a part of the 
decision making along with the donor to alley some of the fears associated with donation. 
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In fact despite the donors voluntarily donating the organ, 40.5% were either unsure 
(38.7%) or felt it was likely (1.8%) to have complications per operative or long term 
morbidity like renal failure. 
 
The commonest reason for a donor not coming forward to donate was due to 
spouse’s negative coercion followed by no disclosed reasons for not donating. One case 
of donor withdrawing consent was due to horseshoe kidney in the donor. 
 
For the 382 prospective recipients there were 1725 age matched donors with a 4.5 
donors per recipient. Interestingly the male female ratio was approximately 1:1 (884 
males, 853 females) among the total number of the donors. One third (34.8%, 600/1725) 
of the donor pool never was requested for donation , 8.8%, 152/1725 was thought to be 
ABO blood group incompatible, 7.1%, 123/1725 declined to donate and 35.5%, 613/1725 
were rejected from donation. Despite 45 near relative other than the first degree relative 
and spousal donors consented to donate 19.1%, 73/382 prospective recipients did not 
have a donor.  
 
We observed that compared to the group that successfully got a transplant done or 
were waiting for the transplant surgery the group of patient who left our centre without 
renal transplant had more number of prospective recipients who did not have a donor 
(62/207, 30%), had less female prospective donors (92/207, 44.4% ) , were more likely to 
Be coerced not to donate (29/207, 14%) and were less often were sponsored either partly 
or fully (75/207, 36.2%).  
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Conclusion: 
 
In this study of patients with chronic kidney disease, stage 5 we made the following 
observations: 
1. The renal replacement options chosen by the patients were – conservative 
treatment 40.8% (513/1257), dialytic therapy 25.5% (320/1257) and renal 
transplantation 33.7% (424/1257). 
2. There was no significant difference in the age and gender among the three above 
groups. 
3. The socio-economic status (SES) and it components – monthly family income, 
level of education and occupation were significantly different among the three 
groups with patients with higher choosing dialysis or transplantation as the 
modality of treatment. 
4. Mother, sister and wife contributed as donors to 57.14% of the patients who 
actually got transplant done here. 
5. The commonest cause of rejection of the donor from donating was ABO blood 
group incompatibility (45.8%, 281/382), followed by diabetes mellitus or a risk of 
diabetes mellitus 24% (147/382). 
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6. The donor came forward for organ donation at the recipient’s request in 29.6% 
cases followed by from recipient’s physician in 25.7%. The donor himself/ herself 
came forward in 28% of cases. 
7. We observed negative coercion for donation in 12% of cases and 7.1% of the 
donors declined to donate.  
8. 40.5% of the donors were unsure or felt I was likely to have per operative 
complication or morbidity like renal failure. 
9. The risk factors we identified among the prospective recipients who left our 
program were – absence of donor, male donor, attempted negative coercion to 
donate and absence of financial support by the governmental or non governmental 
institutions either fully or partly.  
10. The transplant expenses were fully sponsored in 25% (96/382) and partly 
sponsored in 18.1% (69/382) of patients. 
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PROFOMA 
 
 
 
 
 
 
  
 
 
 
                                                                          r 
CKD 5 TREATMENT MODAILTY CHOICE  
Name:    Age:  Sex: M/F Location:   
NKD:   GFR:       ml/min (CG),        ml/min (Abv.MDRD) 
SOCIO-ECONOMIC STATUS (Score Card) 
 
(A) Education Score     (B) Occupation Score 
1. Professional or Honours                               7 1. Profession 10 
2. Graduate or Post-Graduate     6 2. Semi-Profession 6 
3. Intermediate or Post-High-School Diploma 5 3. Clerical, Shopowner, Farmer 5 
4. High School Certificate      4 4. Skilled worker 4 
5. Middle School Certificate      3 5. Semi-skilled worker 3 
6. Primary School or literate      2 6. Unskilled worker 2 
7. Illiterate        1 7. Unemployed 1 
 
(C) Family Income Per Month Score           Total Score         Socioeconomic Class 
Rupees    Score                  26-29                          Upper (I) 
> 13500    12                       16-25                   Upper Middle (II) 
6750-13499    10                        11-15                        Middle (III) 
5050-6749    6                          5-10                     Upper Lower (IV) 
3375-5049    4                           <5                              Lower (V) 
2025-3374    3 
676 -2024    2 
< 675     1 
 
FAMILY DETAILS (Family Tree, identify AGE, SEX, MARITAL STATUS, 
POTENTIAL DONORS) 
 
 
 
 
 
Fit / Not Fit (For Transplant) 
 
 
Total Donors:             
 Actual: 
       Perceived: 
Option Chosen: CONSERV     HD     CAPD        TX 
 
Reason for Choosing Conserv. Rx: No Donor / No Money / Not willing/Not Fit 
 
Reason for Choosing Dialysis       : No Donor / No Money / Not willing/Not Fit 
 
Reason for Choosing Tranaplant : No Donor / No Money / Not willing/Not Fit 
 
 
 
 
 
 DONOR EVALUATION: Recip. Name :  No:   
Donor Name:     Age:  Sex:         H.No. 
1. Donor’s Relationship to Recipient:  
GENDER FAMILY RELATIONSHIP DONOR 
M F SIBLING PARENT CHILD COUSIN OTHERS
POTENTIAL        
ACTUAL        
2. Donor’s Decision to Donate:    
                  Voluntary                             Requested to consider donation 
FAMILY 
MEMBER 
RECIPIENT 
? 
RECIPIENT’S 
PHYSICIAN 
OTHER 
HEALTH 
CARE 
PERSONAL 
OTHERS 
3. Attempted to influence decision: FOR Donation                  Against Donation 
 
4. If attempted to Influence Decision, Who? 
FAMILY 
MEMBER 
RECIPIENT 
? 
RECIPIENT’S 
PHYSICIAN 
OTHER 
HEALTH 
CARE 
PERSONAL 
OTHERS 
 
5. STEP I Blood Group  A   B     AB    +  -- AC           PC             Urea                Cr   
 
Urinalysis: Hematuria / Proteinuria +/ 2+/ 3+ / 4+  
 
HIV -- / +                    HBsAg -- / +               Anti-HBc   -- / +                       HCV  -- / + 
 
6. STEP II Tissue Typing      Recipient     A   B  DR 
                                                    Donor            A                          B                    DR     
7. Gynecology Examination 
8. Hep   B    Vaccine 
9. STEP III   HB                     TC                                DC 
10. PT    PTT  Platelet  ESR 
11. Stool 
12. Uric Acid   Calcium   Phos 
13. LFT 
14. GTT      Fasting  1 hr  1 ½ hr  2 hr 
15. Cholesterol  TG  HDL  LDL 
16. 24 Hour Urine Protein / Volume 
17. VDRL: Non –Reactive  Reactive in …………..Dilution 
18. Urine Culture 
19. ECG 
20. Chest X-Ray 
21. ECHO/ Cardiac Clearance 
22. STEP IV  IVP 
23. STEP V  CT Angiogram/ Urology Clearance  
24. Final Cross Match 
25 Any Other 
  
26. Mean Evaluation Period: _________ Days. 
 27. Reason for Delay: A. Investigational Delay:                    B. Patient Related Delay:  
                          a. HLA                                                a. Medical illness: 
                                     b. Cross Match +                                 _______________________ 
                                     c. Others____________________      b. Others_______________ 
 
28. Early Complication after Nephrectomy: Pneumothorax         Fever         UTI 
       Atelectasis        Retroperitoneal Bleeding        Wound Hematoma  
       Bladder Overdistension  
 
29. At Discharge: 
       Mean Creatinine after Donation: 
       Mean Cr. Cl. after Donation: 
       Mean Arterial Pressure: 
       Protein/Cr ratio: 
 
30. No. of Days in Hospital: 
 
31. Reason for Longer stay: 
32. Decision to Donate affected by patient’s perception of recipient’s health? Yes        No  
 
33. Mental Health Problem requiring professional help?  Yes           No 
 
34. Global assessment of effects of Donation by the donor. 
       Not Harmful                Somewhat Harmful                 Adversely affected 
 35. Relationship with the recipient post transplant- 
      No change       Somewhat improved       Substantially improved      Worsened 
 
36. If provided the opportunity to reconsider the decision to donate 
      Definitely donate        Probably donate         Equivocal         Unlikely to donate 
 
37. Expenditure of donor covered by - 
     Insurance         Company        Recipient         Others: _________________________ 
 
 
 
